On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Parathyroid Disorders and Treatments

TopicLeading institutions, researchers & key papers

Parathyroid Disorders and Treatments is a topic indexed in ScholarIQ from OpenAlex.

What is known about Parathyroid Disorders and Treatments?

ScholarIQrecord summary

This cluster of papers focuses on the complex interplay of FGF23, phosphate, calcification, and mineral metabolism in the context of chronic kidney disease. It explores the role of parathyroid hormone, vascular health, and the impact of Klotho deficiency on mineral homeostasis. The cluster also delves into the implications of hyperphosphatemia and calcification on cardiovascular risk in patients with chronic kidney disease.

How many works does Parathyroid Disorders and Treatments have?

ScholarIQindexed works

Parathyroid Disorders and Treatments has 565 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Parathyroid Disorders and Treatments?

ScholarIQopenalex

The OpenAlex for Parathyroid Disorders and Treatments is on the source record.

What are the most-cited papers on Parathyroid Disorders and Treatments?

ScholarIQmost cited works
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Geoffrey A. Block, Preston Klassen, J. Michael Lazarus, Norma J. Ofsthun, Edmund G. Lowrie, Glenn M. Chertow
Journal of the American Society of Nephrology. 20042,694 Citations
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow, Keith A. Hruska, Craig B. Langman, Hartmut H. Malluche, Kévin Martin, Linda McCann, James T. McCarthy, Sharon M. Moe, Isidro B. Salusky, Donald J. Sherrand, Miroslaw Smogorzewski, Kline Bolton, Charles M. Turkelson, Karyn A. Tappe, Stephen Tregear, James Reston, Wendy Bruening, Mark Monteforte, Janice L Kaczmarek, Vivian Coates, George R. Bailie, Bryan Becker, Gavin J. Becker, Jerrilynn D. Burrowes, Fernando Carrera, David Churchill, Alan Collins, Peter Crooks, Dick de Zeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Cynda Ann Johnson, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda M. Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Thomas H. Hostetter, Garabed Eknoyan, Aderra Levin, Nathan W. Levin, Sharon Andreoli, S Burrows-Hudson, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Brian J.G. Pereira, Nadine Ferguson, Donna Fingerhut, Anthony Gucciardo, Margaret Klette, Doreen Mallard, Kerry Willis
Data Archiving and Networked Services (DANS). 20032,541 Citations
FGF23 induces left ventricular hypertrophy
Christian Faul, Ansel P. Amaral, Behzad N. Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mündel, Azorides R. Morales, Julia J. Scialla, Michael J. Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal A. Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro‐o, John W. Kusek, Martin Keane, Myles Wolf
Journal of Clinical Investigation. 20112,006 Citations
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
Kenneth E. White, W. Evans, Jeffery L.H. O'Riordan, Marcy C. Speer, Michael J. Econs, Bettina Lorenz‐Depiereux, Monika Grabowski, Thomas Meitinger, Tim M. Strom
Nature Genetics. 20001,530 Citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
Adeera Levin, George L. Bakris, Mark E. Molitch, Maartje Smulders, Jianhua Tian, Laura Williams, D.L. Andress
Kidney International. 20061,515 CitationsOPEN ACCESS

Where is Parathyroid Disorders and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Parathyroid Disorders and Treatments is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
0%
Bronze
27%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial